Phio Pharmaceuticals Corp. · NASDAQ:PHIO
Bitterman Robert J bought 25,000 Phio Pharmaceuticals Corp. shares (Form 4)
Traded Nov 9, 2026 · Filed Nov 10, 2026
On Nov 9, 2026, Bitterman Robert J (Director, Chairman, Pres. & CEO) bought 25,000 Phio Pharmaceuticals Corp. shares at US$0.82 for US$20,500, leaving 789,871 shares. Filed Nov 10, 2026 (Form 4).
- Bought
- 25,000 shares
- Price
- US$0.82
- Value
- US$20,500
- Holding after
- 789,871 shares
- Trading plan
- No
- Role
- Director, Chairman, Pres. & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | Common Stock, $.0001 par value | Buy | 25,000 | US$0.82 | 789,871 | Direct |
Source
Download original · View original at SEC
Related
- Phio Pharmaceuticals Corp.
- Bitterman Robert J
- Phio Pharmaceuticals Corp. shareholders
- Form 4 · Bitterman Robert J · Sep 29, 2026
- Form 4 · Bitterman Robert J · Sep 23, 2026
- Form 4 · Bitterman Robert J · Sep 15, 2026
- Form 4 · Bitterman Robert J · Aug 19, 2026
- Form 4 · Bitterman Robert J · Jun 29, 2026
- Form 4 · Deming David H · Nov 16, 2026
- Schedule 13G/A · CVI Investments, Inc. · Nov 16, 2026
- Form 4 · Deming David H · Nov 12, 2026
- Form 4 · Plott Ronald Todd · Nov 10, 2026
- Form 4 · Plott Ronald Todd · Sep 30, 2026